John Nicholls Selected Research

John Nicholls Research Topics

Disease

7	Neoplasms (Cancer) 01/2019 - 05/2004
6	Nasopharyngeal Carcinoma 11/2013 - 03/2004
3	Ulcerative Colitis 04/2011 - 08/2003
2	Neuroblastoma 05/2019 - 05/2004
2	Infections 11/2018 - 05/2007
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 11/2011 - 06/2004
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Influenza in Birds (Avian Flu) 11/2018
1	Constipation 02/2016
1	Colitis 04/2011
1	Crohn Disease (Crohn's Disease) 04/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2010
1	Acute Lung Injury 04/2008
1	Lung Injury 04/2008
1	Anthrax 04/2008
1	Human Influenza (Influenza) 05/2007
1	Wounds and Injuries (Trauma) 06/2004
1	Short Bowel Syndrome 06/2004
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 03/2004
1	Hodgkin Disease (Hodgkin's Disease) 03/2004
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2003
1	Retinoblastoma (Glioblastoma, Retinal) 09/2002

Drug/Important Bio-Agent (IBA)

2	DNA (Deoxyribonucleic Acid)IBA 12/2004 - 09/2002
1	Signaling Lymphocytic Activation Molecule Associated ProteinIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 05/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	Polysaccharides (Glycans)IBA 11/2018
1	Ligases (Synthetase)IBA 11/2013
1	UbiquitinIBA 11/2013
1	olaparibIBA 11/2013
1	Poly (ADP-Ribose) Polymerase-1IBA 11/2013
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2013
1	Temozolomide (Temodar)FDA LinkGeneric 11/2013
1	Viral AntigensIBA 03/2012
1	Immunologic Factors (Immunomodulators)IBA 04/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2011
1	AnnexinsIBA 12/2010
1	EphrinsIBA 12/2010
1	MicroRNAs (MicroRNA)IBA 04/2009
1	PlatinumIBA 07/2008
1	Gefitinib (Iressa)FDA Link 07/2008
1	Toll-Like Receptor 4IBA 04/2008
1	CytokinesIBA 04/2008
1	oxidized- L- alpha- 1- palmitoyl- 2- arachidonoyl- sn- glycero- 3- phosphorylcholineIBA 04/2008
1	Phospholipids (Phosphatides)FDA LinkGeneric 04/2008
1	1-penicillamyl-Leu(2)- oxytocinIBA 04/2008
1	AcidsIBA 04/2008
1	Oncogene Proteins (Oncogene Protein)IBA 09/2007
1	Hazardous Substances (Hazardous Materials)IBA 05/2007
1	Hemagglutinins (Hemagglutinin)IBA 05/2007
1	VaccinesIBA 05/2007
1	Biomarkers (Surrogate Marker)IBA 12/2004
1	Macrophage Migration-Inhibitory FactorsIBA 05/2004
1	N-Myc Proto-Oncogene ProteinIBA 05/2004
1	Interleukin-8 (Interleukin 8)IBA 05/2004
1	Messenger RNA (mRNA)IBA 05/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2004
1	Proteins (Proteins, Gene)FDA Link 05/2004
1	Monoclonal AntibodiesIBA 03/2004
1	Transcription Factors (Transcription Factor)IBA 09/2002
1	Cyclin-Dependent Kinase Inhibitor p16IBA 09/2002

Therapy/Procedure

4	Therapeutics 01/2019 - 12/2004
3	Restorative Proctocolectomy 11/2011 - 08/2003
2	Immunotherapy 01/2019 - 03/2012
2	Drug Therapy (Chemotherapy) 11/2013 - 07/2008
2	Elective Surgical Procedures 06/2004 - 08/2003
1	Transcutaneous Electric Nerve Stimulation (TENS) 02/2016
1	Chemoradiotherapy 11/2013
1	Radiotherapy 11/2013
1	Parenteral Nutrition 06/2004